In conclusion, the present study demonstrated that cynaroside promoted ketone body production in the liver through the up-regulation of HMGCS2, which in turn inhibited hepatocyte senescence in order to ameliorate NASH-combined T2DM and slow down the progression of liver disease. Here, HMGCS2 is linked to metabolic dysfunction-associated steatohepatitis.